SCHEMBL21834573

SCHEMBL21834573

CN(C(=O)C1(CC(=O)O)Cc2ccccc2C1)c1nc(-c2cccnc2)cs1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.56
▸ RAB9A P51151 6/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ GRM1 Q13255 4/20 0.52
▸ GFER P55789 1/20 0.50
▸ UCHL1 P09936 1/20 0.47
▸ USP30 Q70CQ3 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ GSTO1 P78417 1/20 0.44
▸ CYP19A1 P11511 2/20 0.43
▸ KMT2A Q03164 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ CDK5R1 Q15078 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21834551 0.91 GRM1 (0.57) NPC1RAB9AALOX15GRM1UCHL1
SCHEMBL21834637 0.86 NPC1 (0.51) NPC1RAB9AALOX15GRM1GFER
SCHEMBL21834575 0.85 RAB9A (0.46) NPC1RAB9AALOX15GRM1GFER
SCHEMBL21834566 0.85 RAB9A (0.47) NPC1RAB9AALOX15GRM1UCHL1
SCHEMBL21834549 0.84 GRM1 (0.52) NPC1RAB9AALOX15GRM1UCHL1
SCHEMBL21834574 0.83 SMN1; SMN2 (0.45) NPC1RAB9AALOX15GRM1UCHL1
SCHEMBL21834679 0.82 RAB9A (0.43) NPC1RAB9AALOX15GRM1UCHL1
SCHEMBL21834611 0.81 FFAR2 (0.41) NPC1RAB9AALOX15GRM1UCHL1
SCHEMBL21834645 0.81 NPC1 (0.54) NPC1RAB9AALOX15GRM1UCHL1
SCHEMBL21834701 0.80 SMN1; SMN2 (0.44) NPC1RAB9AALOX15GRM1UCHL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020064175-A1 INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION ANTABIO SAS (FR) 2020-04-02 — — WO disclosed
Send feedback